“Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management” (2025) Canadian Diabetes & Endocrinology Today, 3(s01), pp. 2–8. doi:10.58931/cdet.2025.3s0144.